Reference
Walker AM, et al. Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors. Pharmacoepidemiology and Drug Safety : [9 pages], 23 Dec 2013. Available from: URL: http://doi.org/10.1002/pds.3558
Rights and permissions
About this article
Cite this article
No increased cardiac death with olmesartan. Reactions Weekly 1489, 4 (2014). https://doi.org/10.1007/s40278-014-8892-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-8892-2